Lp-PLA2: an emerging biomarker of coronary heart disease. - Wikidata - wikimedia - TriplyDB

Lp-PLA2: an emerging biomarker of coronary heart disease.

Lp-PLA2: an emerging biomarker of coronary heart disease.

http://www.wikidata.org/entity/Q34606938

about

Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque.Age as a modulator of inflammatory cardiovascular risk factors.Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.Pharmacotherapy for dyslipidaemia--current therapies and future agents.Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Candidate-based proteomics in the search for biomarkers of cardiovascular disease.Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction PLAC test for identification of individuals at increased risk for coronary heart disease.Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.Associations of platelet-activating factor acetylhydrolase gene polymorphisms with risk of ischemic stroke.Distinct urinary lipid profile in children with focal segmental glomerulosclerosis Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance.From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.Inflammation, atherosclerosis, and psoriasis.Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease.Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.Expression and purification of lipoprotein-associated phospholipase A(2), a key enzyme involved in atherosclerosis.Secreted phospholipase A2 enzymes as therapeutic targets.Lipoprotein-associated phospholipase A2: a new marker to determine cardiovascular risk in hypercholesterolemic dyslipidaemic children.

P2860

Q28389004-72072178-B004-49D0-BD26-11E080B458F3 Q33814212-35D8FA87-954B-4542-B027-22FBDEA89288 Q33849524-C83E97AB-C64E-4D11-AC74-91591DE6DBCC Q34384281-DDAAEEFF-09B1-4B1A-959A-DE228303D3E3 Q34837405-BE900E3E-E2C3-4B8E-B57E-7003C6EF0C46 Q35171257-F72FF0F1-10FE-42B4-8CEF-1B11968FB061 Q35225272-15A751B6-AA0E-4E4F-9F8A-3A5D2030B861 Q35574960-39C6E756-B48A-4282-A21C-9ABCE90CC6ED Q35621992-DB65CC94-F694-4D67-BB94-6732C9D891AC Q35990040-F69A68F4-9344-4B21-AD9E-ABB4334B31AB Q36013005-CE34AFF5-0252-479A-BD39-7D251EC84A27 Q36050527-B7B16F9C-0057-4570-97E1-3D969FB087B3 Q36187055-75A53C79-CD6B-4433-80EF-811AB129FE0F Q36269180-76EDF924-D0FE-4946-A4D1-6782DA2DC71F Q36524201-FA0FE274-F9B3-41E6-952D-2CCC05C7C4F0 Q37130343-EFAD4817-5A9F-4D5C-8FD6-B06B6F30A2C7 Q37264593-60F3F183-6A36-42FA-95D3-3BDB7326657F Q37617482-C9BA57C5-0A8F-4BFA-82A2-8227526368FA Q37881966-7B16D87E-BBA0-4812-AF19-D3E5A686196E Q37987473-4B6BC265-15C4-4281-B698-60A790BE8C82 Q39050736-3ECB2A79-1095-4487-BAA7-53B45822876A Q39354235-2BAD2861-3703-4BE5-AAA7-E3C165ED1A87 Q40275828-2891DA35-0DBB-47DE-9C4F-6762198965A9 Q40584187-1DD8883E-37CF-487B-8353-E9F2959EEBF3 Q40587146-761F1A62-B701-424B-8E72-A8C2A85577E6

P2860

Lp-PLA2: an emerging biomarker of coronary heart disease.

http://www.wikidata.org/entity/Q34606938

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Lp-PLA2: an emerging biomarker of coronary heart disease.

@ast

Lp-PLA2: an emerging biomarker of coronary heart disease.

@en

Lp-PLA2: an emerging biomarker of coronary heart disease.

@nl

type

label

Lp-PLA2: an emerging biomarker of coronary heart disease.

@ast

Lp-PLA2: an emerging biomarker of coronary heart disease.

@en

Lp-PLA2: an emerging biomarker of coronary heart disease.

@nl

prefLabel

Lp-PLA2: an emerging biomarker of coronary heart disease.

@ast

Lp-PLA2: an emerging biomarker of coronary heart disease.

@en

Lp-PLA2: an emerging biomarker of coronary heart disease.

@nl

P1433

Q34606938-D5147374-5001-4782-B9DB-4224E5E3867F

P1476

Q34606938-20CF02EA-94C2-4327-94FB-5B4F36B5D31E

P2093

Q34606938-25CCD664-5AE7-4FB3-A4C6-8D65BBE34200

Q34606938-A334D263-E1DB-4B35-8B17-61215FA8F1F9

Q34606938-BADC7B35-9DF9-4844-B004-50C04DBC73A3

P2860

Q34606938-31B9F2CB-0367-4DE0-AA37-CC32DF83CBE0

Q34606938-8D27C86C-78B8-450A-AA35-928E7126BA3C

Q34606938-ABCC13B0-8AB7-49C5-BB92-F98A93B33C50

P304

Q34606938-3FE760CF-7034-4861-B78C-F35416690231

P31

Q34606938-06C9CFD3-89B4-4E66-944D-1DF59A66F712

P356

Q34606938-4DA2F201-0C41-46EC-916F-DC85F15ECA4B

P433

Q34606938-325F717B-7AFC-4005-B870-F3E8363F4F7F

P478

Q34606938-572DD69A-F5CD-4CFA-9BCE-38BC825BD805

P577

Q34606938-408E1E81-9065-4497-959A-E4473CF57B45

P698

Q34606938-B26BFC3F-AA0B-462F-8EDB-85A1D124992D

P921

Q34606938-EEE7EFD8-4B7C-4743-87BD-9EC6AE12EDF5

P356

14737159.2.1.17

P1433

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

P1476

Lp-PLA2: an emerging biomarker of coronary heart disease.

@en

P2093

Nam W Kim

http://www.w3.org/2001/XMLSchema#string

Nisha Dada

http://www.w3.org/2001/XMLSchema#string

Robert L Wolfert

http://www.w3.org/2001/XMLSchema#string

P2860

HDL, its enzymes and its potential to influence lipid peroxidation.

The oxidation hypothesis of atherosclerosis.

Lipoprotein-associated PLA2 inhibition--a novel, non-lipid lowering strategy for atherosclerosis therapy.

P304

17-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737159.2.1.17

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11963798

http://www.w3.org/2001/XMLSchema#string

P921